Dare Bioscience, Inc. DARE Balance Sheet

Dare bioscience, inc. (DARE)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13
Assets
Current assets
Cash and cash equivalents
5,047	4,780	2,435	5,600	3,505	6,805	9,537	12,446	15,625	7,559	8,529	-	12,028	44	38,058	47,193	60,515	-	77,631	85,476	56,316	51,174	57,786	64,271	8,468	5,488
Other receivables
429	555	37	493	166	31	80	24	28	284	710	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable, prepaid expenses, and other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,146	1,729	1,586	-	1,522	1,609	2,266	1,662	1,912	1,123	3,033	959
Property and equipment held for sale
-	-	-	-	-	-	-	-	-	-	-	-	386	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	1,139	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid retention payments
-	-	-	-	-	-	-	-	-	-	-	-	1,069	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
-	-	-	-	-	-	-	-	-	-	1,143	-	987	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash
-	-	-	-	-	-	-	-	-	-	-	39	-	-	-	-	-	219	-	-	-	-	-	-	-	-
Prepaid expenses
3,844	1,108	770	437	588	403	549	347	290	311	-	-	-	-	-	-	-	250	-	-	-	-	-	-	-	-
Other current assets
-	-	-	-	-	-	-	-	-	193	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets
9,321	6,443	3,243	6,561	4,260	7,240	10,167	12,818	15,944	8,349	10,383	39	15,609	44	39,204	48,922	62,101	469	79,153	87,085	58,582	52,836	59,698	65,394	11,501	6,447
Property and equipment, net
51	63	5	7	8	9	10	7	-	0	-	-	114	-	699	740	693	-	354	366	330	342	268	221	223	245
Goodwill
-	-	-	-	-	-	-	-	-	5,187	12,880	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-current assets
840	935	632	692	751	577	617	657	686	723	2	2	230	12	230	230	230	-	610	653	469	215	120	124	130	135
Total assets
10,213	7,442	3,882	7,260	5,019	7,827	10,795	13,483	16,630	14,259	23,266	42	15,953	44	40,133	49,892	63,024	469	80,117	88,104	59,381	53,393	60,086	65,739	11,854	6,827
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
-	-	352	632	325	-	1,202	1,265	807	-	839	-	-	12	-	-	-	-	-	-	-	-	-	-	-	-
Convertible promissory notes
-	-	-	-	-	-	-	-	-	-	-	852	-	697	-	-	-	500	-	-	-	-	-	-	17,324	8,824
Interest payable
-	-	-	-	-	-	-	-	-	-	-	79	-	45	-	-	-	2	-	-	-	-	-	-	-	-
Accounts payable
1,531	1,083	-	-	-	459	-	-	-	308	-	563	644	-	1,778	1,593	2,190	13	2,158	1,808	1,682	1,255	1,461	579	2,160	914
Accrued expenses
1,690	2,098	1,536	1,341	690	631	-	-	-	658	-	-	3,538	-	5,919	4,852	5,559	-	4,402	3,356	2,736	3,648	1,571	2,110	1,493	2,274
Deferred grant funding
1,089	2,019	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of lease liabilities
404	410	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,192	8,017	7,832	-	4,031	2,654	836	3,124	3,347	3,274	3,203	3,134
Current portion deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	2,500	-	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17	27	35	34	-	-	-	-
Total current liabilities
4,715	5,612	1,888	1,973	1,016	1,091	1,202	1,265	807	966	839	1,494	6,682	755	15,889	14,462	15,581	516	10,608	7,845	5,289	8,061	6,379	5,963	24,180	15,146
Deferred license revenue
1,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contingent consideration
1,000	1,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loan payable, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,550	8,649	10,687	-	10,530	11,833	13,576	-	587	1,451	2,297	3,124
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	1,368	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-current accrued interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	336	224	108	-	-	-	-	-
Preferred stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	424	928
Noncurrent accrued interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	543	-	-	391
Noncurrent accrued interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	503	-	-
Noncurrent accrued interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	452	-
Lease liabilities long-term
284	389	183	203	223	9	-	-	-	-	-	-	162	-	1,075	941	773	-	-	-	-	7	45	14	14	12
Deferred rent
-	-	-	-	-	-	9	0	2	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total liabilities
6,999	7,001	2,072	2,177	1,239	1,100	1,212	1,265	810	967	839	1,494	-	755	-	-	-	516	-	-	-	-	-	-	-	-
Total long-term liabilities
-	-	-	-	-	-	-	-	-	-	-	-	1,530	-	7,625	9,590	11,460	-	10,866	12,057	13,684	7	1,175	1,968	3,187	4,455
Redeemable convertible preferred stock (Note 8)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	81,525	81,525
Commitments and contingencies (Note 8)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders' equity
Preferred stock, $0.01 par value, 5,000,000 shares authorized; None issued and outstanding
0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	-	0	0	0	0	0	0	-	0
Common stock, $0.0001 par value; 120,000,000 shares authorized; 24,700,553 and 19,683,401 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
2	1	1	1	1	1	1	1	1	0	0	9	3	0	3	3	3	8	3	3	2	2	2	2	0	-
Accumulated other comprehensive loss
-125	-102	-112	-97	-89	-96	-78	-59	-31	-18	-9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Additional paid-in capital
51,612	44,564	42,077	41,942	35,889	35,791	35,713	35,754	35,747	25,541	25,535	8	214,757	17	212,351	211,613	210,897	0	209,307	208,315	170,615	167,104	-	-	-	-
Additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	166,844	166,562	4,315	4,140
Accumulated deficit
-48,275	-44,023	-40,200	-36,800	-32,021	-28,969	-26,053	-23,478	-19,896	-12,230	-3,099	-1,469	-207,019	-727	-195,735	-185,776	-174,917	-55	-150,667	-140,116	-130,209	-121,781	-114,314	-108,756	-	-98,439
Deficit accumulated during the development stage
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	101,353	-
Total stockholders' equity
3,214	440	1,809	5,083	3,780	6,726	9,583	12,217	15,820	13,292	22,427	-1,452	7,741	-710	16,619	25,840	35,983	-46	58,643	68,202	40,408	45,325	52,532	57,808	-97,038	-94,299
Total liabilities and stockholders' equity
10,213	7,442	3,882	7,260	5,019	7,827	10,795	13,483	16,630	14,259	23,266	42	15,953	44	40,133	49,892	63,024	469	80,117	88,104	59,381	53,393	60,086	65,739	11,854	6,827